Literature DB >> 28693179

Association between periostin and epithelial-mesenchymal transition in esophageal squamous cell carcinoma and its clinical significance.

Ya-Jing Lv1, Wei Wang1, Chu-Shu Ji1, Ming-Ran Xie2, Bing Hu1.   

Abstract

The present study aimed to investigate the association between periostin (POSTN), epithelial cadherin (E-cad) and vimentin (Vim) expression levels in esophageal squamous cell carcinoma (ESCC) tissues, and its clinicopathological significance. A total of 58 patients with esophageal cancer were enrolled. Immunohistochemistry was performed to quantify the expression levels of POSTN, E-cad and Vim. E-cad expression was reduced in ESCC tissue, which was associated with severe tumor node metastasis (TNM) stage (P<0.001), lymphatic metastasis (P<0.001) and vascular invasion (P=0.026). Conversely, Vim expression was found to be increased in ESCC tissues, and had associations with TNM stage (P=0.039) and lymphatic metastasis (P=0.039). POSTN overexpression observed in ESCC cells was associated with attenuation of E-cad expression (P<0.001) and elevated expression levels of Vim (P<0.001). Additionally, significant correlations between the overexpression of POSTN in ESCC cells and clinicopathological variables including TNM staging (P=0.009), degree of differentiation (P<0.001), lymphatic metastasis (P=0.009) and vascular invasion (P=0.002) were verified. Multivariate analysis revealed that overexpression of POSTN in ESCC cancer cells is able to predict the poor prognosis of patients independently of overall survival (P=0.022) and disease free survival (P=0.019). The preliminary findings of the present study demonstrate that POSTN is involved in the epithelial-mesenchymal transition of ESCC cells, and may therefore be a predictive factor for tumor invasion and metastasis, as well as an indicator of poor prognosis for patients with ESCC.

Entities:  

Keywords:  clinicopathological factors; epithelial cadherin; epithelial-mesenchymal transition; esophageal squamous cell carcinoma; periostin; vimentin

Year:  2017        PMID: 28693179      PMCID: PMC5494835          DOI: 10.3892/ol.2017.6124

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  35 in total

1.  Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer.

Authors:  Lisa Ryner; Yinghui Guan; Ron Firestein; Yuanyuan Xiao; Younjeong Choi; Christina Rabe; Shan Lu; Eloisa Fuentes; Ling-Yuh Huw; Mark R Lackner; Ling Fu; Lukas C Amler; Carlos Bais; Yulei Wang
Journal:  Clin Cancer Res       Date:  2015-04-02       Impact factor: 12.531

2.  Imaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer.

Authors:  Pedram Heidari; Shadi A Esfahani; Nazife S Turker; Gabrielle Wong; Timothy C Wang; Anil K Rustgi; Umar Mahmood
Journal:  J Nucl Med       Date:  2015-06-11       Impact factor: 10.057

3.  SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.

Authors:  Min-Sun Jin; Chang Lim Hyun; In Ae Park; Ji Young Kim; Yul Ri Chung; Seock-Ah Im; Kyung-Hun Lee; Hyeong-Gon Moon; Han Suk Ryu
Journal:  Tumour Biol       Date:  2015-10-30

4.  Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma.

Authors:  Yi Jiang; Liyan Liao; Chandrama Shrestha; Shangli Ji; Ying Chen; Jian Peng; Larry Wang; Eryuan Liao; Zhongjian Xie
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

5.  Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.

Authors:  Qingfeng Hu; Shijun Tong; Xiaojun Zhao; Weihong Ding; Yuancheng Gou; Ke Xu; Chuanyu Sun; Guowei Xia
Journal:  Cell Physiol Biochem       Date:  2015-05-22

6.  Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.

Authors:  Lindsay Gillan; Daniela Matei; David A Fishman; C S Gerbin; Beth Y Karlan; David D Chang
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

7.  Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells.

Authors:  Atsushi Kanno; Kennichi Satoh; Atsushi Masamune; Morihisa Hirota; Kenji Kimura; Jun Umino; Shin Hamada; Akihiko Satoh; Shinichi Egawa; Fuyuhiko Motoi; Michiaki Unno; Tooru Shimosegawa
Journal:  Int J Cancer       Date:  2008-06-15       Impact factor: 7.396

8.  Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway.

Authors:  Shideng Bao; Gaoliang Ouyang; Xuefang Bai; Zhi Huang; Chaoyu Ma; Ming Liu; Rong Shao; Ryan M Anderson; Jeremy N Rich; Xiao-Fan Wang
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

9.  Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.

Authors:  Alex Soltermann; Verena Tischler; Stefanie Arbogast; Julia Braun; Nicole Probst-Hensch; Walter Weder; Holger Moch; Glen Kristiansen
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

10.  Overexpression of periostin predicts poor prognosis in non-small cell lung cancer.

Authors:  Ling-Zhi Hong; Xiao-Wei Wei; Jin-Fei Chen; Yi Shi
Journal:  Oncol Lett       Date:  2013-09-18       Impact factor: 2.967

View more
  8 in total

1.  Stromal expression of cancer-associated fibroblast-related molecules, versican and lumican, is strongly associated with worse relapse-free and overall survival times in patients with esophageal squamous cell carcinoma.

Authors:  Naoto Yamauchi; Yasuyuki Kanke; Katsuharu Saito; Hirokazu Okayama; Shoki Yamada; Shotaro Nakajima; Eisei Endo; Koji Kase; Leo Yamada; Hiroshi Nakano; Takuro Matsumoto; Hiroyuki Hanayama; Yohei Watanabe; Suguru Hayase; Motonobu Saito; Zenichiro Saze; Kosaku Mimura; Tomoyuki Momma; Shinji Oki; Yuko Hashimoto; Koji Kono
Journal:  Oncol Lett       Date:  2021-04-06       Impact factor: 2.967

Review 2.  Periostin in Allergy and Inflammation.

Authors:  Eva Sonnenberg-Riethmacher; Michaela Miehe; Dieter Riethmacher
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

3.  Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma.

Authors:  Weihong Xie; Guiying Sun; Jicun Zhu; Huimin Wang; Zhuo Han; Peng Wang
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

Review 4.  Cancer Stem Cells in Tumor Microenvironment of Adenocarcinoma of the Stomach, Colon, and Rectum.

Authors:  Jose Francisco Islas; Adriana G Quiroz-Reyes; Paulina Delgado-Gonzalez; Hector Franco-Villarreal; Juan Luis Delgado-Gallegos; Elsa N Garza-Treviño; Carlos A Gonzalez-Villarreal
Journal:  Cancers (Basel)       Date:  2022-08-16       Impact factor: 6.575

5.  Solid Stress Facilitates Fibroblasts Activation to Promote Pancreatic Cancer Cell Migration.

Authors:  Maria Kalli; Panagiotis Papageorgis; Vasiliki Gkretsi; Triantafyllos Stylianopoulos
Journal:  Ann Biomed Eng       Date:  2018-02-22       Impact factor: 3.934

6.  Integrated Bioinformatics Analysis Identifies Hub Genes Associated with the Pathogenesis and Prognosis of Esophageal Squamous Cell Carcinoma.

Authors:  Hui Zhang; Jianing Zhong; Youbing Tu; Benquan Liu; Zhibo Chen; Yunchen Luo; Yaping Tang; Fei Xiao; Jincai Zhong
Journal:  Biomed Res Int       Date:  2019-12-26       Impact factor: 3.411

7.  Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT-dependent pathway in colorectal cancer cell migration.

Authors:  Suyanee Thongchot; Ekapot Singsuksawat; Nuttavut Sumransub; Ananya Pongpaibul; Attaporn Trakarnsanga; Peti Thuwajit; Chanitra Thuwajit
Journal:  J Cell Mol Med       Date:  2020-09-29       Impact factor: 5.310

8.  Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis.

Authors:  Rui Zhou; Denghua Liu; Jing Zhu; Tao Zhang
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.